Cargando…

High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer

PURPOSE: The identification of prognostic markers for colorectal cancer (CRC) is needed for clinical practice. Fructose-bisphosphate aldolase A (ALDOA) and DEAD box p68 RNA helicase (DDX5) are commonly overexpressed in cancer and correlate with tumorigenesis. However, association between expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Ling, Pan, Guangdong, Liu, Xiaojia, Huang, Jiang, Jiang, Zhiqing, Zhu, Xiaobao, Gan, Xinli, Xu, Qing, Tan, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029611/ https://www.ncbi.nlm.nih.gov/pubmed/29988738 http://dx.doi.org/10.2147/CMAR.S157925

Ejemplares similares

Overexpression of DDX49 in prostate cancer is associated with poor prognosis
por: Tao, Junyue, et al.
Publicado: (2023)

The ALDOA Metabolism Pathway as a Potential Target for Regulation of Prostate Cancer Proliferation
por: Kuang, Qiwen, et al.
Publicado: (2021)

LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability
por: Han, Lijie, et al.
Publicado: (2023)

Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
por: Lu, Guojun, et al.
Publicado: (2021)

NONHSAG028908.3 sponges miR‑34a‑5p to promote growth of colorectal cancer via targeting ALDOA
por: Wang, Chuanzhuo, et al.
Publicado: (2023)

Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer
por: Heerma van Voss, Marise R, et al.
Publicado: (2017)

MiR-122 Promotes the Development of Colon Cancer by Targeting ALDOA In Vitro
por: Li, Hong, et al.
Publicado: (2019)

DDX39 Overexpression Predicts a Poor Prognosis and Promotes Aggressiveness of Melanoma by Cooperating With SNAIL
por: Xing, Chengjuan, et al.
Publicado: (2020)

High GSTP1 inhibits cell proliferation by reducing Akt phosphorylation and is associated with a better prognosis in hepatocellular carcinoma
por: Liu, Xiaojia, et al.
Publicado: (2017)

RRP9 and DDX21 as new biomarkers of colorectal cancer
por: Chi, Xiaoqian, et al.
Publicado: (2023)

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer
por: Abdel-Fatah, T M A, et al.
Publicado: (2014)

LncRNA ZNF674-AS1 regulates granulosa cell glycolysis and proliferation by interacting with ALDOA
por: Li, Duan, et al.
Publicado: (2021)

Blockade of PGK1 and ALDOA enhances bilirubin control of Th17 cells in Crohn’s disease
por: Vuerich, Marta, et al.
Publicado: (2022)

MKL-1-induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA-mediated glycolysis
por: Wang, Jun, et al.
Publicado: (2022)

The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity
por: Lin, Jinguan, et al.
Publicado: (2022)

DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer
por: Su, Chia-Yi, et al.
Publicado: (2015)

DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression
por: Xu, Kun, et al.
Publicado: (2022)

Elevated transcriptional levels of aldolase A (ALDOA) associates with cell cycle-related genes in patients with NSCLC and several solid tumors
por: Zhang, Fan, et al.
Publicado: (2017)

GABRD promotes progression and predicts poor prognosis in colorectal cancer
por: Niu, Gengming, et al.
Publicado: (2020)

Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction
por: Wang, Hao, et al.
Publicado: (2021)

The glycolytic enzyme ALDOA and the exon junction complex protein RBM8A are regulators of ribosomal biogenesis
por: Schwarz, Jessica Denise, et al.
Publicado: (2022)

Corrigendum: DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression
por: Xu, Kun, et al.
Publicado: (2023)

LncRNA KCNQ1OT1 sponges miR-34c-5p to promote osteosarcoma growth via ALDOA enhanced aerobic glycolysis
por: Shen, Yifei, et al.
Publicado: (2020)

IGFBP5 is Upregulated and Associated with Poor Prognosis in Colorectal Cancer
por: Deng, Yu, et al.
Publicado: (2022)

Macrosphelide A Exhibits a Specific Anti-Cancer Effect by Simultaneously Inactivating ENO1, ALDOA, and FH
por: Song, Kyoung, et al.
Publicado: (2021)

A novel lncRNA ARST represses glioma progression by inhibiting ALDOA-mediated actin cytoskeleton integrity
por: Sun, Jun, et al.
Publicado: (2021)

Erratum: The glycolytic enzyme ALDOA and the exon junction complex protein RBM8A are regulators of ribosomal biogenesis
por: Frontiers Production Office,
Publicado: (2022)

DDX3X Biomarker Correlates with Poor Survival in Human Gliomas
por: Hueng, Dueng-Yuan, et al.
Publicado: (2015)

O‐GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of DDX5
por: Wu, Nan, et al.
Publicado: (2018)

DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathway
por: Shen, Lin, et al.
Publicado: (2022)

Downregulation of LRRC19 Is Associated with Poor Prognosis in Colorectal Cancer
por: Wang, Ya-Juan, et al.
Publicado: (2022)

DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma
por: Bao, Yewei, et al.
Publicado: (2021)

Knockdown of DDX5 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer
por: Ma, Zhenchuan, et al.
Publicado: (2017)

Functions of DEAD box RNA helicases DDX5 and DDX17 in chromatin organization and transcriptional regulation
por: Giraud, Guillaume, et al.
Publicado: (2018)

Intestinal obstruction: predictor of poor prognosis in colorectal carcinoma?
por: Mohd Suan, Mohd Azri, et al.
Publicado: (2015)

The Chemokine CXCL7 Is Related to Angiogenesis and Associated With Poor Prognosis in Colorectal Cancer Patients
por: Li, Longhai, et al.
Publicado: (2021)

Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis
por: Chen, Gang, et al.
Publicado: (2021)

THOC5 complexes with DDX5, DDX17, and CDK12 to regulate R loop structures and transcription elongation rate
por: Polenkowski, Mareike, et al.
Publicado: (2022)

AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer
por: Tian, Wenwen, et al.
Publicado: (2023)

Associations of DDX60L With the Clinical Features and Prognosis of Hepatocellular Carcinoma
por: Ye, Ziqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3vjmmiedunrnk98a202b05ae7k